| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 02/15/1995 | EP0637961A1 Methods for treating inflammatory bowel disease with leukotriene synthesis inhibitors |
| 02/15/1995 | EP0627900A4 Use of injectable biomaterials for the repair and augmentation of the anal sphincters. |
| 02/15/1995 | CN1098715A 1H-indole-3-acetamide spla2 inhibitors |
| 02/15/1995 | CN1098714A 1H-indole-3-acetic acid hydrazide spla2 inhibitors |
| 02/14/1995 | US5389684 Naphthalene carboxamides |
| 02/14/1995 | US5389683 Useful in treating or preventing a disorder of the melatoninergic system |
| 02/14/1995 | US5389666 Administering for treatment and prevention of thrombosis, arteriosclerosis, ischemic heart diseases, gastric ulcer or hypertension |
| 02/14/1995 | US5389649 Relax vascular smooth muscle |
| 02/14/1995 | US5389643 Aminobenzoic acid derivatives useful for treating gastro-intestinal conditions |
| 02/14/1995 | US5389634 Imidazole derivatives having angiotensin II receptor antagonistic activity |
| 02/14/1995 | US5389612 Phosphonic peptide inhibitors of bacterial collagenases |
| 02/14/1995 | CA1334408C Dithiolane derivatives |
| 02/09/1995 | WO1995004051A1 Piperazine compounds used in therapy |
| 02/09/1995 | WO1995004047A1 2-benzoheterocyclyloxy or thiopropanolamine derivatives with adreno receptor agonist activity |
| 02/09/1995 | WO1995004045A1 Compounds as pde iv and tnf inhibitors |
| 02/09/1995 | WO1995004042A1 4-phenyl-4-phenylpropyl(enyl)-piperidines as tachykinin antagonists |
| 02/09/1995 | WO1995003777A1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus |
| 02/09/1995 | CA2167411A1 4-phenyl-4-phenylpropyl(enyl)-piperidines as tachykinin antagonists |
| 02/08/1995 | EP0637333A1 Ifn receptors recognition factors, protein sequences and methods of use thereof |
| 02/08/1995 | EP0637241A1 Synergistic combination of a substance with gastric acid secretion inhibiting effect and an acid degradable antibiotic |
| 02/08/1995 | EP0637203A1 Regulation of the immune system |
| 02/08/1995 | CN1098406A New benzamide derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same |
| 02/07/1995 | CA1334282C Periodontal composition and method |
| 02/06/1995 | CA2129483A1 Bicyclic derivatives of imidazole, process for their preparation, new intermediate compounds thus obtained, their application as medicaments, and pharmaceutical compositions containing them |
| 02/06/1995 | CA2129374A1 Carbonamides, pharmaceutical compositions containing these compounds and processes for their preparation |
| 02/03/1995 | CA2129279A1 Pharmaceutical composition and process |
| 02/02/1995 | WO1995003369A1 Storage stable partially neutralized acid compositions and uses |
| 02/02/1995 | WO1995003333A2 Tryptase inhibitor |
| 02/02/1995 | WO1995003305A1 Fused benzazepine derivative and pharmaceutical composition containing the same |
| 02/02/1995 | WO1995003304A1 Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 02/02/1995 | WO1995003285A1 1,5-benzodiazepine derivatives useful as cck or gastrin antagonists |
| 02/02/1995 | WO1995003284A1 1,5-benzodiazepine derivatives useful as cck or gastrin antagonists |
| 02/02/1995 | WO1995003281A1 Tetrahydro-1h-benzazepinones and hexahydroazepinones as selective cholecystokinin-b receptor antagonists |
| 02/02/1995 | WO1995003036A1 Anti-angiogenic compositions and methods of use |
| 02/02/1995 | CA2472404A1 Combination of stent and anti-angiogenic factor |
| 02/02/1995 | CA2468375A1 Anti-angiogenic compositions, uses and methods |
| 02/02/1995 | CA2167721A1 Storage stable partially neutralized acid compositions and uses |
| 02/02/1995 | CA2167308A1 1,5-benzodiazepine derivatives useful as cck or gastrin antagonists |
| 02/02/1995 | CA2164221A1 Tryptase inhibitor |
| 02/01/1995 | EP0636625A2 Tricyclic diazepine vasopressin antagonists and oxytocin antagonists |
| 02/01/1995 | EP0636614A1 Derivatives of 1-benzenesulfonyl-1,3-dihydro-2H-benzimidazol-2-one, their preparation and pharmaceutical compositions containing them |
| 02/01/1995 | EP0636609A1 1-Benzyl-1,3-dihydro-indol-2-one derivatives, their preparation, the pharmaceutical compositions containing them |
| 02/01/1995 | EP0636608A1 Derivatives of 1-benzenesulfonyl-1,3-dihydro-indol-2-one, their preparation and pharmaceutical compositions containing them |
| 02/01/1995 | EP0636580A1 Dried aluminum hydroxide gel, a method for preparing the dried gel, and an antacid |
| 02/01/1995 | EP0636378A1 Absorbable composite materials for use in the treatment of periodontal disease |
| 02/01/1995 | EP0636368A1 The use of 2- phenylmethylene -1- 3'-(amino)-2'-(hydroxy)--propoxy-imino -cyclohexane derivatives |
| 02/01/1995 | EP0636125A1 Basic derivatives of glutamic acid and aspartic acid as gastrin or cholecystokinin antagonists |
| 02/01/1995 | EP0636124A1 3,4-dihydro-2h-1,2,4-benzothiadiazine-1,1-dioxide-3-carboxylic acid derivatives, preparation thereof and drugs containing same |
| 02/01/1995 | EP0636123A1 3-ureido substituted benzodiazepin-2-ones having cholecystokinin and/or gastrin antagonistic activity and their use in therapy |
| 02/01/1995 | EP0549594B1 (2-imidazolin-2-ylamino) quinoxaline derivatives and methods for using same |
| 02/01/1995 | EP0486561B1 Buccal composition containing s(+) flurbiprofen or ketoprofen |
| 01/31/1995 | US5386034 2-(alkoxy benzothiazolinon-3yl) ethylamines |
| 01/31/1995 | US5385944 Treating or preventing disorders of melatoninergic system |
| 01/31/1995 | US5385942 Quinone derivatives and pharmacological use |
| 01/31/1995 | US5385923 Treatment of degenerative diseases |
| 01/31/1995 | US5385922 Thiazolidine derivatives |
| 01/31/1995 | CA2129215A1 1-benzenesulfonyl-1,3-dihydro-indol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present |
| 01/31/1995 | CA2129214A1 1-benzenesulfonyl-1,3-dihydro-2h-benzimidazol-2-one derivatives |
| 01/27/1995 | CA2127739A1 Dried aluminum hydroxide gel, a method for preparing the dried gel, and an antacid |
| 01/26/1995 | WO1995002595A1 Benzyloxyquinuclidines as substance p antagonists |
| 01/26/1995 | WO1995002591A1 Tri-substituted imidazoles having multiple therapeutic properties |
| 01/26/1995 | WO1995002406A2 Use of benzothiophenes and benzofurans for the treatment of inflammatory bowel disease and inflammation assay method |
| 01/26/1995 | CA2167311A1 Tri-substituted imidazoles having multiple therapeutic properties |
| 01/26/1995 | CA2163542A1 Benzothiophenes and benzofurans as agents of therapeutic use in the treatment of inflammatory bowel disease and methods for assaying inflammation |
| 01/25/1995 | EP0635519A1 Polyglucuronic acid as remitting agent for nephrotic syndrome and hepatopathy symptoms |
| 01/25/1995 | EP0635018A1 4-(1H-2-METHYLIMIDAZO 4,5-c]PYRIDINYLMETHYL)PHENYLSULPHONAMIDE DERIVATIVES AS ANTAGONISTS OF PAF |
| 01/25/1995 | CN1097758A Pyrrolopyrimidines |
| 01/24/1995 | US5384327 Anticonvulsant sorbopyranose sulfamates |
| 01/24/1995 | CA2038409C Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase |
| 01/24/1995 | CA1334095C Aroyl urea and carbamic acid derivatives |
| 01/21/1995 | CA2128354A1 Pharmaceutical compositions for the prevention and/or treatment of gastrointestinal diseases including ulcer |
| 01/19/1995 | WO1995001977A1 Magnesium omeprazole |
| 01/19/1995 | WO1995001976A1 Indoline derivatives as 5ht2c antagonists |
| 01/19/1995 | WO1995001965A1 3,5-dioxo-(2h,4h)-1,2,4-triazine derivatives as 5ht1a ligands |
| 01/19/1995 | WO1995001795A1 H2 antagonist-alginate-antacid combinations |
| 01/19/1995 | WO1995001783A1 New pharmaceutical formulation |
| 01/19/1995 | WO1995001782A2 Method for making freeze dried drug dosage forms |
| 01/19/1995 | WO1994026891A3 Purified mammalian flt3 ligands and agonists and antagonists thereof |
| 01/19/1995 | CA2166731A1 H2 antagonist-alginate-antacid combinations |
| 01/19/1995 | CA2166629A1 3,5-dioxo-(2h,4h)-1,2,4-triazine derivatives as 5ht1a ligands |
| 01/19/1995 | CA2166624A1 Indoline derivatives as 5ht2c antagonists |
| 01/18/1995 | CN1097419A New preparation process for sulphurated derivatives of imidazole and the new intermediates obtained |
| 01/17/1995 | US5382601 Memantine-containing solid pharmaceutical dosage forms having an extended two-stage release profile and production thereof |
| 01/17/1995 | US5382571 Clathrates of peroxyacids, their preparation and their uses |
| 01/17/1995 | CA2128160A1 Cation-complexed polysaccharides |
| 01/16/1995 | CA2127934A1 Remitting agent for nephrotic syndrome and hepatopathy symptoms |
| 01/12/1995 | WO1995001170A2 Use of phenethanolamine derivatives in the treatment of gastrointestinal disorders |
| 01/12/1995 | WO1995001168A2 Pharmaceutical preparations that contain an active substance with modified amidine groups |
| 01/11/1995 | EP0633259A1 Sulfonylaminopyrimidines, their preparation and their use as medicine |
| 01/11/1995 | EP0633023A2 Preventing emesis and treating sexual dysfunction using tetrahydrobenz CD indole-6-carboxamides |
| 01/11/1995 | EP0632809A1 Quinuclidine derivatives as substance p antagonists |
| 01/11/1995 | CN1097130A Traditional Chinese herbal medicine product for treating lithiasis diseases by external application |
| 01/11/1995 | CN1027368C Process for preparing substituted quinoline derivatives |
| 01/10/1995 | US5380742 4H-thieno[3,4-c]pyrrole derivatives |
| 01/10/1995 | US5380736 Cholecystokinin and gastric antagonist |
| 01/10/1995 | US5380724 Piperazine and homopiperazine derivatives, pharmaceutical compositions containing them and process for preparing same |
| 01/10/1995 | US5380723 Indole derivatives |
| 01/10/1995 | US5380717 Food composite for performing function of large bowel regulation |
| 01/10/1995 | US5380525 Ruminal bacterium for preventing acute lactic acidosis |
| 01/05/1995 | WO1995000844A1 Novel clinical marker and therapeutic agent in kidney stone disease and methods of use |